The cells were negative for anti-cytokeratin, CD3, and CD10 antibodies but positive for CD20, bcl2, and MUM1 antibodies, indicating a diffuse large B-Cell malignant lymphoma (DLBCL) with a non-germinal center phenotype (Fig. 1). Here, BCL2 is linked to diffuse large B-cell lymphoma.